OR WAIT null SECS
Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.
Sexually transmitted diseases and infections (STDs/STIs) are common health issues in the United States, according to Kenneth J. Tomecki, MD, staff physician in the department of dermatology at the Cleveland Clinic, and past president of the American Academy of Dermatology.1 He cited 2018 data from the Centers for Disease Control and Prevention (CDC) that revealed 1 in 5 people in the United States had an STI. In that year alone, there were 26 million newly acquired STIs, nearly 50% of which were acquired by people aged 15 to 24 years. Nearly $16 billion was spent on direct medial costs.2
In light of these statistics, it is important that physicians expand their knowledge about different STDs and how to treat them, Tomecki said.
Tomecki ended his presentation with key facts about the STDs/STIs in 20223:
Originally published on our sister brand, Dermatology Times.
Tomecki reported no relevant disclosures.